rs777215134
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005677.4(COLQ):āc.242A>Gā(p.Asn81Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,613,514 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_005677.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COLQ | NM_005677.4 | c.242A>G | p.Asn81Ser | missense_variant | 3/17 | ENST00000383788.10 | NP_005668.2 | |
COLQ | NM_080538.2 | c.212A>G | p.Asn71Ser | missense_variant | 3/17 | NP_536799.1 | ||
COLQ | NM_080539.4 | c.219+1240A>G | intron_variant | NP_536800.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COLQ | ENST00000383788.10 | c.242A>G | p.Asn81Ser | missense_variant | 3/17 | 1 | NM_005677.4 | ENSP00000373298.3 | ||
COLQ | ENST00000603808.5 | c.242A>G | p.Asn81Ser | missense_variant | 3/17 | 1 | ENSP00000474271.1 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152162Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250510Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135442
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461352Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727002
GnomAD4 genome AF: 0.000335 AC: 51AN: 152162Hom.: 2 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74342
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 5 Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 13, 2023 | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 81 of the COLQ protein (p.Asn81Ser). This variant is present in population databases (rs777215134, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with COLQ-related conditions. ClinVar contains an entry for this variant (Variation ID: 536242). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COLQ protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Apr 11, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Nov 15, 2017 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2023 | The c.242A>G (p.N81S) alteration is located in exon 3 (coding exon 3) of the COLQ gene. This alteration results from a A to G substitution at nucleotide position 242, causing the asparagine (N) at amino acid position 81 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at